Dopamine transporter (DAT) imaging is a diagnostic tool to support the diagnosis of Parkinson’s disease (PD) by determining if there is loss of functional nigrostriatal dopaminergic neurons [1]. This evidence concerns the gene SLC6A3 and Parkinson disease.